Scinovex
article Open Access

Comparison of steroid injection and platelet-rich plasma injection in the treatment of De-Quervain Tenosynovitis

International Journal of Orthopaedics Sciences · 2021 · Vol. 7(3) · pp. 463–466
Chetan GirotiAkshat MittalDhaval Gotecha

Abstract

Aim: The aim of this study was to evaluate the therapeutic effect of corticosteroid and platelet-rich plasma (PRP) injections in the treatment of De Quervain Tenosynovitis. Methods: The study group comprised of 49 patients with 50 hands divided into two groups. In the corticosteroid group (Group A; n=28), 1 ml of methylprednisolone (40 mg/ml) was injected along with 1 ml of 0.5% bupivacaine. In the PRP group (Group B; n=22), PRP was obtained from the patients’ own blood and injected in a single dose. Patients were evaluated using Visual analogue scale (VAS), the shortened disabilities of the arm, shoulder and hand questionnaire (DASH) at baseline, one and three months after the injection. Results: Overall, 44 females and 5 males were included with 28 hands in Group A and 22 hands in Group B. The CS group had better pain relief, hand function tests at 1 month and at 3 months follow-up, the PRP group had better pain relief, hand function tests than CS group. Conclusion: PRP therapy proves to be more effective in relieving pain than corticosteroid injections in treatment of De-Quervain Tenosynovitis.

Orthopedic Surgery and RehabilitationShoulder Injury and TreatmentElbow and Forearm Trauma TreatmentMedicinePlatelet-rich plasmaTenosynovitisCorticosteroidMethylprednisoloneMethylprednisolone acetateVisual analogue scaleGroup BSurgeryAnesthesia
Citations
4
FWCI
0.63
field-weighted impact
References
11
Percentile
69%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Comparison of steroid injection and platelet-rich plasma injection in the treatment of De-Quervain Tenosynovitis · Scinovex